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Tricuspid Atresia (TA) is a congenital heart disease in which the tricuspid valve is missing or abnormally 
developed. The defect blocks blood in the right atrium from flowing directly into the right ventricle. It is 
an uncommon form of congenital heart disease that affects about 5 in every 100,000 live births. While the 
cause of TA is unknown, the lab data shows that in mice loss of transcription factor Hand2 function 
within a population of cells that line the inside of the heart (the endocardium) results in a TA phenotype. 
Hand2 is a protein that belongs to the basic helix-loop-helix family of transcription factors, and has been 
shown to play many different roles in embryonic development. To test whether loss of Hand2 function in 
humans results in TA, sequencing the HAND2 gene in 25 TA patients. Polymerase Chain Reaction (PCR) 
was used to amplify the TA patient Hand2 alleles. A  TOPO reaction was then performed to insert the 
amplicons into a sequencing plasmid, followed by a transformation and minipreps to isolate individual 
clones. Isolated Hand2 alleles within the TOPO sequencing plasmid were sent to a sequencing core 
facility. In this manner the Hand2 DNA sequence for several patients was obtained and analyzed for 
mutations. This project will shed light on the cause of TA. Further research is currently in progress in Dr. 
Firulli’s Lab. 
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